A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study (Q73640509)
Jump to navigation
Jump to search
scientific article published on 01 April 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study |
scientific article published on 01 April 2000 |
Statements
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study (English)
F J Giles
J Shan
S Chen
S H Advani
I Supandiman
Z Aziz
A P Caviles
G Y Tee
M R Chasen
Z Fahed
T Y Chaoj
I Aydogdu